Thyroid disease and vascular function

Thyroid

Volumn 17, Issue 6, 2007, Pages 519-524

  Owen, Penelope J D ^a   Sabit, Ramsey ^a   Lazarus, John H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROXINE;

BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HEART FUNCTION; HEMODYNAMICS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; THYROXINE BLOOD LEVEL;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THYROID DISEASES; THYROID HORMONES;

EID: 34447517228     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0051     Document Type: Review

References (79)

1. Hayashi T, Nakayama Y, Tsumura K, Yoshimaru K, Ueda H 2002 Reflection in the arterial system and the risk of coronary heart disease. Am J Hypertens 15:405-409.
2. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B 2004 Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109:184-189.
3. Imanishi R, Seto S, Toda G, Yoshida M, Ohtsuru A, Koide Y, Baba T, Yano K 2004 High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 27:71-78.
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM 1999 Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439.
5. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. 2006 Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113:657-663.
6. Boutouyrie P, Tropeano AI, Asmar R, et al. 2002 Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39:10-15.
7. Davies JI, Struthers AD 2003 Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens 21:463-472.
8. Wilkinson IB, Hall I, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu Y, MacKay LS, Webb DJ, Cockcroft JR 2002 Pulse wave analysis - clinical evaluation of a non-invasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22:147-152.
9. Patti G, Melfi R, Di Sciascio G 2005 The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences. Recenti Prog Med 96:499-507.
10. Cockcroft JR 2005 Exploring vascular benefits of endothelium-derived nitric oxide. Am J Hypertens 18:177-183.
11. McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin, Newby DE, Cockcroft JR, Wilkinson IB 2006 Endothelial function is associated with pulse pressure, pulse wave velocity and augmentation index in healthy humans. Hypertension 48:602-608.
12. Jadhav UM, Kadam NN 2005 Non-invasive assessment of arterial stiffness by pulse-wave velocity correlates with endothelial dysfunction. Indian Heart J 57:226-232.
13. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR 2005 Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 46:1753-1760.
14. Laurent S, Cockcroft J, Van Bortel L, et al. 2006 Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588-2605.
15. Stamatelopoulos KS, Kalpakos D, Protogerou AD, Papamichael CM, Ikonomidis I, Tsitsirikos M, Revela I, Papaioannou TG, Lekakis JP 2006 The combined effect of augmentation index and carotid intima-media thickness on cardiovascular risk in young and middle-aged men without cardiovascular disease. J Hum Hypertens 20:273-279.
16. Wada T, Fukumoto T 2000 Biomechanical diagnosis of atherosclerosis by ultrasound. Methods Inf Med 39:246-248.
17. Raitakari OT, Celermajer DS. 2000 Flow mediated dilatation. Br J Clin Pharmacol 50:397-404.
18. Higashi Y, Yoshizumi M 2003 New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain gauge plethysmography: nitric oxide-dependent and independent vasodilation. J Pharmacol Sci 93:399-404.
19. Kester MH, Kuiper GG, Versteeg R, Visser TJ 2006 Regulation of type III iodothyronine deiodinase expression in human cell lines. Endocrinology 147:5845-5854.
20. Yazuzawa-Amano S, Toyoda N, Maeda A, Kosaki A, Mori Y, Iwasaka T, Nishikawa M 2004 Expression and regulation of type 2 iodothyronine deiodinase in rat aorta media. Endocrinology 145:5638-5645.
21. Kasahara T, Tsunekawa K, Seki K, Mori M, Murakami M 2005 Regulation of iodothyronine deiodinase and roles of thyroid hormones in human coronary artery smooth muscle cells. Atherosclerosis 186:207-214.
22. Mizuma H, Murakami M, Mori M 2001 Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res 88:313-318.
23. Davis PJ, Davis FB 1996 Non-genomic actions of thyroid hormone. Thyroid 6:497-504.
24. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, Noma K, Ueki K, Nguyen NH, Scanlan TS, Moskowitz MA, Cheng SY, Liao JK 2006 Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103:14104-14109.
25. Klemperer JD, Zelano J, Helm RE, Berman K, Ojamaa K, Klein I, Isom OW, Krieger K1995 Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischaemia. J Thorac Cardiovasc Surg 109:457-465.
26. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Kreiger K 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1522-1527.
27. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Effects of thyroid hormone on cardiac function - the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87:968-974.
28. Vinzio S, Morel O, Schlienger JL, Goichot B 2005 Cellular mechanisms of thyroid hormone action. Presse Med 24:1123-1124.
29. Ojamaa K, Klemperer JD, Klein I 1996 Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6:505-512.
30. Vargas F, Fernandez-Rivas A, Garcia Estan J, Garcia del Rio C 1995 Endothelium-dependent and endothelium independent vasodilation in hyperthyroid and hypothyroid rats. Pharmacology 51:308-314.
31. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, Angelini V, Fazio S, Sacca L 2001 Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 104:3076-3080.
32. Burggraaf J, Lalezari S, Emeis JJ, Vischer UM, de Meyer PH, Pijl H, Cohen AF 2001 Endothelial function in patients with hyperthyroidism before and after treatment with propanolol and thiamazole. Thyroid 11:153-160.
33. Guang-da X, Hong-yan C, Xian-mei Z 2004 Changes in endothelium-dependent arterial dilation before and after subtotal thyroidectomy in subjects with hyperthyroidism. Clin Endocrinol 61:400-404.
34. Napoli R, Guardasole V, Angelini V, Zarra E, Terracciano D, D'Anna C, Matarazzo M, Oliviero U, Macchia V, Sacca L 2006 Acute effects of triiodothyronine on endothelial function in human subjects. J Clin Endo Metab Oct 17 Epub.
35. Obuobie K, Smith J, John R, Davies JS, Lazarus JH 2002 The effects of thyrotoxicosis and its treatment on central arterial stiffness. Eur J Endocrinol 147:35-40.
36. Inaba M, Henmi Y, Kumeda Y, Ueda M, Nagata M, Emoto M, Ishikawa T, Ishimura E, Nishizawa Y 2002 Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients. Biomed Pharmacother 56:241-246.
37. Cooper DS 2007 Approach to the patient with subclinical hyperthyroidism. J Clin Endocrinol Metab 92:3-9.
38. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534.
39. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, Sacca L, Bellastella A, Lombardi G 1993 Cardiac effects of long term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334-338.
40. Shargorodsky M, Serov S, Gavish D, Leibovitz E, Harpaz D, Zimlichman R 2006 Long term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma. Thyroid 16:381-386.
41. Auer J, Berent R, Weber T, Lassnig E, Eber B 2003 Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 26:569-573.
42. Biondi B, Klein I 2004 Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24:1-13.
43. Kosar F, Sahin I, Aksoy Y, Uzer E, Turan N 2006 Usefulness of pulsed-wave Doppler echocardiography for the assessment of the left and right ventricular function in patients with clinical hypothyroidism. Echocardiography 23:471-477.
44. Papaioannou GI, Lagasse M, Mather JF, Thompson PD 2004 Treating hypothyroidism improves endothelial function. Metabolism 53:278-279.
45. Dernellis J, Panaretou M 2002 Effects of thyroid replacement on arterial blood pressure in patients with hypertension and hypothyroidism. Am Heart J 143:718-724.
46. Mayer O Jr, Simon J, Filipovsky J, Plaskova M, Pikner R 2006 Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vasc Health Risk Manag 2:499-506.
47. Giannattasio CM, Rivolta MR, Failla M, Mangoni AA, Stella ML, Mancia G 1997 Large and medium sized artery abnormalities in untreated and treated hypothyroidism. Eur Heart J 18:1492-1498.
48. Obuobie K, Smith J, Evans LM, John R, Davies JS, Lazarus JH 2002 Increased central arterial stiffness in hypothyroidism. J Clin Endo Metab 87:4662-4666.
49. Dagre AG, Lekakis JP, Papamichael CM, Koutras DA, Stamatelopoulos SF, Alevizaki M 2005 Arterial stiffness is increased in subjects with hypothyroidism. Int J Cardiol 103:1-6.
50. Hamano K, Inoue M 2005 Increased risk for atherosclerosis estimated by pulse wave velocity in hypothyroidism and its reversal with appropriate thyroxine treatment. Endocr J 52:95-101.
51. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos, Stamatelopoulos S, Koutras DA 1997 Flow mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high normal serum thyrotropin (TSH) values. Thyroid 7:411-414.
52. Xiang GD, He YS, Zhao LS, Hou J, Yue L, Xiang HJ 2006 Impairment of endothelium-dependent arterial dilation in Hashimototo's thyroiditis patients with euthyroidism. Clin Endocrinol 64:698-702.
53. Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A, Monzani F 2006 Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 91:4175-4178.
54. Owen PJ, Rajiv C, Vinereanu D, Mathew T, Fraser AG, Lazarus JH 2006 Subclinical hypothyroidism, arterial stiffness and myocardial reserve. J Clin Endocrinol Metab 91:2126-2132.
55. Taddei S, Caraccio N, Virdis A, Dardanao A, Versari D, Ghiadoni L, Ferrannini E, Monzani F 2003 Impaired endothelium-dependent vasodilation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731-3737.
56. Nagasaki T, Inaba M, Kumeda Y, Hiura Y, Shirakawa K, Yamada S, Henmi Y, Ishimura E, Nishizawa Y 2006 Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 91:154-158.
57. Vanderpump M 2003 Subclinical hypothyroidism: the case against treatment. Trends Endocrinol Metab 14:262-266.
58. Owen PJ, Lazarus JH 2003 Subclinical hypothyroidism: the case for treatment. Trends Endocrinol Metab 14:257-261.
59. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley-Evans J, Hasan DM, Rodgers H, Tunbridge F, et al. 1995 The incidence of thyroid disorders in the community: a twenty year follow-up of the Whickham Survey. Clin Endocrinol 43:55-68.
60. Cikim AS, Oflaz H, Ozbey N, Cikim K, Umman S, Meric M, Sencer E, Molvalilar S 2004 Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid 14:605-609.
61. Nagasaki T, Inaba M, Kumeda Y, Hiura Y, Yamada S, Shirakawa K, Ishimura E, Nishizawa Y 2007 Central pulse wave velocity is responsible for increased brachial-ankle pulse wave velocity in subclinical hypothyroidism. Clin Endocrinol 66:304-308.
62. Monzani F, Caraccio N, Kosakowa M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C, Ferrannini E 2004 Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo controlled study. J Clin Endocrinol Metab 89:2099-2106.
63. Delp MD, McAllister RM, Laughlin MH 1995 Exercise training alters aortic vascular reactivity in hypothyroid rats. Am J Physiol 268:H1428-H1435.
64. McAllister RM, Luther KL, Pfeifer PC 2000 Thyroid status and response to endothelin-1 in rat arterial vessels. Am J Physiol Endocrinol Metab 279:E252-E258.
65. Bussemaker E, Popp R, Fisslthaler B, Larson CM, Fleming I, Busse R, B Brandes RP Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery. Cardiovasc Res 59:181-188.
66. McAllister RM, Albarracin I, Price EM, Smith TK, Turk JR, Wyatt KD 2005 Thyroid status and nitric oxide in rat arterial vessels. J Endocrinol 185:111-119.
67. Yoneda K, Takasu N, Higa S, Oshiro C, Oshiro Y, Shimabukuro M, Asahi T 1998 Direct effects of thyroid hormones on rat coronary artery: nongenomic effects of triiodothyronine and thyroxine. Thyroid 8:609-613.
68. Zwaveling J, Pfaffendorf M, van Zwieten PA 1997 The direct effects of thyroid hormones on rat mesenteric resistance arteries. Fundam Clin Pharmacol 11:41-46.
69. Fukuyama K, Ichiki T, Imayama I, Ohtsubo H, Ono H, Hashiguchi Y, Takeshita A, Sunagawa K 2006 Thyroid hormone inhibits vascular remodelling through suppression of CAMP response element binding protein activity. Arterioscler Thromb Vasc Biol 26:2049-2055.
70. Park KW, Dal HB, Lowenstein E, Sellke FW 1995 Propofol-associated dilation of rat coronary arteries is mediated by multiple substances, including endothelium-derived nitric oxide. Anesth Analg 81:1191-1196.
71. Park KW, Dai HB, Lowenstein E, Darvish A, Sellke FW 1997 Isoflurane and halothane attenuate endothelium-dependent vasodilation in rat coronary microvessels. Anesth Analg 84:278-284.
72. Hawthorn MH, Gengo P, Wei XY, Rutledge A, Moran JF, Gallant S, Triggle DJ 1988 Effect of thyroid status on beta-adrenoceptors and calcium channels in rat cardiac and vascular tissue. Naunyn Schmiedebergs Arch Pharmacol 337:539-544.
73. Iwata T, Honda H 2004 Acute hyperthyroidism alters adrenoceptor- and muscarinic receptor-mediated responses in isolated rat renal and femoral arteries. Eur J Pharmacol 493:191-199.
74. Sato Y, Nakamura R, Satoh M, Fujishita K, Mori S, Ishida S, Yamaguchi T, Inoue K, Nagao T, Ohno Y 2005 Thyroid hormone targets matrix gla protein gene associated with vascular smooth muscle calcification. Circ Res 97:550-557.
75. Levick S, Fenning A, Brown L 2005 Increased calcium influx mediates increased cardiac stiffness in hyperthyroid rats. Cell Biochem Biophys 43:53-60
76. Grieve DJ, Fletcher S, Pitsillides AA, Botham KM, Elliott J 1999 Effects of oral propylthiouracil treatment on nitric oxide production in rat aorta. Br J Pharmacol 127:1-8.
77. Vargas F, Moreno JM, Rodriguez-Gomez I, Wangensteen R, Osuna A, Alvarez-Guerra M, Garcia-Estan J 2006 Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol 154:197-212.
78. Owen PJ, H Ying, Lang D, Tomlinson D, Lewis MJ, Cheng SY, Lazarus JH 2007 Endothelial dysfunction in a murine model of resistance to thyroid hormone. Eur J Clin Invest 37:390-395.
79. Quesada A, Sainz J, Wangensteen R, Rodriguez-Gomez I, Vargas F, Osuna A 2002 Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol 147:117-122.